Independent research tool — not a government agency. Official notices govern.Refreshed
ClosedResearch announcementOpportunity HT942526NFRPNFRASA

DoW Neurofibromatosis Research Academy – Scholar Award

Defense Health Agency Contracting Activity - DHACA · Department of Defense

At a glance

DoW Neurofibromatosis Research Academy – Scholar Award is a closed federal grant opportunity from the Defense Health Agency Contracting Activity - DHACA (Department of Defense). The application deadline was September 22, 2026. Total estimated funding is $3.6M across about 3 awards. The notice is unrestricted by applicant type, subject to any clarifications in the notice. Cost sharing is not required. It is funded under Assistance Listing 12.420 (Military Medical Research and Development).

Summary assembled from the official notice's fields. The official notice governs.

Key facts

  1. Jun 25, 2026Posted
  2. Sep 22, 2026Application deadline
  3. Oct 22, 2026Archivednext date
Posted
Jun 25, 2026
Close date
Sep 22, 2026
Archive date
Oct 22, 2026
Award floor
Not specified
Award ceiling
Not specified
Est. total funding
$3,600,000
Implied average award
$1,200,000 calculated
Expected awards
3
Cost sharing
Not required
Funding instrument
Grant
Opportunity category
Discretionary

Typical awards for this program (SAM.gov listing for ALN 12.420, not this notice): This Assistance Listing supports approximately 30 or more programs each year. Overall, awards are expected to range from $100,000 to $20M (consortium) depending on the funding priorities, anticipated number of awards, and project activity/scope within each program for an award period, on average, of 3 to 4 years. The maximum award amount, if any, is specified in each Program Announcement or Broad Agency Announcement.

Implied average = estimated total funding ÷ expected number of awards, calculated by GrantsJunction. Actual awards vary.

Who can apply

  • Unrestricted (any entity type)

A quick check against the listed applicant types — other requirements in the notice still apply.

Based on the published notice. Review the official notice for complete eligibility requirements.

What it funds

Official synopsis as published by the agency, formatted for readability.

Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Neurofibromatosis Research Academy – Scholar Award (NFRA-SA) supports early-career independent investigators (Scholars) joining the Neurofibromatosis Research Academy to pursue a neurofibromatosis project that may include basic, translational, and/or clinical research. The proposed research should address at least one of the FY26 NFRP Areas of Emphasis, under the leadership of the NFRA Director and Deputy Director. The overarching goal of the NFRA is to conduct innovative and impactful research in the field of neurofibromatosis disorders while developing successful, highly productive NF researchers in a collaborative research and career development environment.

Distinctive Features:

• Scholar: The Scholar, named as the Principal Investigator, must be less than 10 years of completion of their terminal degree by the time of the application deadline (excluding time spent in residency, clinical training, or on family medical leave).

• Career Guide: This award mechanism requires each Scholar to designate a Career Guide for guidance. The Career Guide is not required to be at the same institution as the Scholar; however, if the (primary) Career Guide is from a different institution, the application must identify a secondary Career Guide at the Scholar’s institution.

Full announcement & documents

The full announcement has the complete rules — page limits, required attachments, evaluation criteria and any letter-of-intent dates. Files download directly from Grants.gov.

Assistance Listing

What is an ALN?

Reported obligations under ALN 12.420

Historical data · not a prediction
FY24$1.48B
FY25$1.2B
FY26— est.
Source: SAM.gov Assistance Listing 12.420. Program-wide totals, not awards from this specific opportunity.

Agency contact (as published)

Ebony S Simmons Grantor
help@eBRAP.org
301-619-2105

Quick answers

Who is eligible to apply for “DoW Neurofibromatosis Research Academy – Scholar Award”?

The notice lists eligibility as unrestricted — open to any type of entity — subject to clarifications in the notice's additional eligibility information.

How much funding is available through “DoW Neurofibromatosis Research Academy – Scholar Award”?

Per the notice, total estimated program funding is $3,600,000 and the agency expects to make about 3 awards.

How do I apply for “DoW Neurofibromatosis Research Academy – Scholar Award”?

Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity HT942526NFRPNFRASA), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.

Matched on shared Assistance Listings, agency, categories and eligible applicant types.

Closes in 13 daysResearchALN 12.420

DoW Arthritis Translational Research Award

Defense Health Agency Contracting Activity - DHACA
Award range
Amount not specified
Closes
Oct 22, 2026
Who can apply
Unrestricted (any entity type)
Source: Grants.govVerified today